WallStreetZenWallStreetZen

NASDAQ: NMRA
Neumora Therapeutics Inc Stock Ownership - Who owns Neumora Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Neumora Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Joshua PintoPresident2026-02-175,967$3.54
$21.09kSell
Daljit Singh AuroraTitle Chief Operating and Development Officer2026-02-176,165$3.56
$21.92kSell
Paul L. BernsTitle Chief Executive Officer and Chairman of the Board2026-02-179,819$3.51
$34.45kSell
Michael Lee MilliganTitle Chief Financial Officer Principal Accounting Officer2026-02-171,436$3.57
$5.12kSell
Daljit Singh AuroraTitle Chief Operating and Development Officer2025-11-11114,703$2.68
$307.06kSell
Arch Venture Partners XII LLC10% Owner2025-10-271,915,700$2.61
$5.00MBuy
Arch Venture Partners X LLC10% Owner2025-10-271,915,700$2.61
$5.00MBuy
Kristina BurowDirector2025-10-271,915,700$2.61
$5.00MBuy

1 of 1

NMRA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NMRA insiders and whales buy or sell their stock.

NMRA Shareholders

What type of owners hold Neumora Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Kristina Burow27.14%49,406,456$120.55MInsider
Amgen Inc19.43%35,368,653$86.30MInsider
Arch Venture Partners XII LLC18.59%33,847,838$82.59MInsider
Arch Venture Partners X LLC18.59%33,847,838$82.59MInsider
Paul L. Berns4.14%7,528,282$18.37MInsider
Softbank Group Corp3.53%6,429,720$15.69MInstitution
Siren LLC3.45%6,288,783$15.34MInstitution
Vanguard Group Inc2.49%4,539,261$11.08MInstitution
MIC Capital Management Uk LLP2.45%4,460,700$10.88MInstitution
Point72 Asset Management LP2.02%3,673,839$8.96MInstitution

1 of 3

NMRA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NMRA27.82%72.18%Net BuyingNet Selling
AVIR71.55%28.12%Net BuyingNet Buying
LYEL0.49%99.51%Net BuyingNet Buying
AURA78.31%15.28%Net SellingNet Selling
PRTC0.04%0.00%
View Top Biotech Stocks

Neumora Therapeutics Stock Ownership FAQ

Who owns Neumora Therapeutics?

Neumora Therapeutics (NASDAQ: NMRA) is owned by 34.66% institutional shareholders, 89.94% Neumora Therapeutics insiders, and 0.00% retail investors. Kristina Burow is the largest individual Neumora Therapeutics shareholder, owning 49.41M shares representing 27.14% of the company. Kristina Burow's Neumora Therapeutics shares are currently valued at $120.55M.

If you're new to stock investing, here's how to buy Neumora Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.